{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:42:54Z","timestamp":1792395774865,"version":"4.4.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00403-020-02152-4","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:03:10Z","timestamp":1604566990000},"page":"391-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-8958","authenticated-orcid":false,"given":"Sherman","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Michelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Ekelem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin T.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Rojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Mesinkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"3","key":"2152_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","volume":"1","author":"A Layton","year":"2009","unstructured":"Layton A (2009) The use of isotretinoin in acne. Dermatoendocrinology 1(3):162\u2013169","journal-title":"Dermatoendocrinology"},{"issue":"5","key":"2152_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1982.tb00410.x","volume":"107","author":"K King","year":"1982","unstructured":"King K, Jones DH, Daltrey DC, Cunliffe WJ (1982) A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 107(5):583\u2013590","journal-title":"Br J Dermatol"},{"issue":"4","key":"2152_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.120529","volume":"46","author":"DK Wysowski","year":"2002","unstructured":"Wysowski DK, Swann J, Vega A (2002) Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol 46(4):505\u2013509","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2152_CR4","first-page":"272","volume":"8","author":"J Chen","year":"2002","unstructured":"Chen J, White T, Juzba M, Chang E (2002) Oral isotretinoin: an analysis of its utilization in a managed care organization. J Manag Care Spec Pharm 8(4):272\u2013277","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"2152_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","volume":"53","author":"CE Orfanos","year":"1997","unstructured":"Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC (1997) Current use and future potential role of retinoids in dermatology. Drugs 53(3):358\u2013388","journal-title":"Drugs"},{"issue":"7","key":"2152_CR6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","volume":"20","author":"AM Layton","year":"2006","unstructured":"Layton AM, Dreno B, Gollnick HP, Zouboulis CC (2006) A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 20(7):773\u2013776","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2152_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","volume":"10","author":"JS Strauss","year":"1984","unstructured":"Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H et al (1984) Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 10(3):490\u2013496","journal-title":"J Am Acad Dermatol"},{"key":"2152_CR8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0014-2964(72)90153-3","volume":"8","author":"W Bollag","year":"1972","unstructured":"Bollag W (1972) Prophylaxis of chemically induced benign and malignant epithelial tumorsby vitamin A acid (retinoic acid). Eur J Cancer 8:689\u2013693","journal-title":"Eur J Cancer"},{"issue":"4","key":"2152_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.det.2015.05.007","volume":"33","author":"AO Huen","year":"2015","unstructured":"Huen AO, Kim EJ (2015) The role of systemic retinoids in the treatment of cutaneous T cell lymphoma. Dermatol Clin 33(4):715\u2013729","journal-title":"Dermatol Clin"},{"issue":"1","key":"2152_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","volume":"40","author":"J Boer","year":"1999","unstructured":"Boer J, van Gemert MJ (1999) Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 40(1):73\u201376","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2152_CR11","first-page":"1275","volume":"20","author":"F Recchia","year":"2002","unstructured":"Recchia F, De Filippis S, Rosselli M, Saggio G, Fumagalli L, Rea S (2002) Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: a phase II study. Int J Oncol 20(6):1275\u20131282","journal-title":"Int J Oncol"},{"issue":"5","key":"2152_CR12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/me.6.5.667","volume":"6","author":"TM Vollberg Sr","year":"1992","unstructured":"Vollberg TM Sr, Nervi C, George MD, Fujimoto W, Krust A, Jetten AM (1992) Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol 6(5):667\u2013676","journal-title":"Mol Endocrinol"},{"key":"2152_CR13","unstructured":"Group OLoEW (2011) The Oxford 2011 Levels of Evidence. [cited; Available from: https:\/\/www.cebm.net\/index.aspx?o=5653"},{"issue":"3","key":"2152_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0738-081X(01)00179-1","volume":"19","author":"MM Bagheri","year":"2001","unstructured":"Bagheri MM, Safai B (2001) Cutaneous malignancies of keratinocytic origin. Clin Dermatol 19(3):244\u2013252","journal-title":"Clin Dermatol"},{"issue":"4","key":"2152_CR15","first-page":"22","volume":"7","author":"SB Nickle","year":"2014","unstructured":"Nickle SB, Peterson N, Peterson M (2014) Updated physician\u2019s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol 7(4):22\u201334","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"2152_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0190-9622(89)80359-7","volume":"21","author":"LH Goldberg","year":"1989","unstructured":"Goldberg LH, Hsu SH, Alcalay J (1989) Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol 21(1):144\u2013145","journal-title":"J Am Acad Dermatol"},{"issue":"4 Pt 2 Suppl","key":"2152_CR17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0190-9622(82)70071-4","volume":"6","author":"GL Peck","year":"1982","unstructured":"Peck GL, Gross EG, Butkus D, DiGiovanna JJ (1982) Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol. 6(4 Pt 2 Suppl):815\u2013823","journal-title":"J Am Acad Dermatol."},{"issue":"1 Pt 2","key":"2152_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0190-9622(88)70162-0","volume":"19","author":"GL Peck","year":"1988","unstructured":"Peck GL, DiGiovanna JJ, Sarnoff DS, Gross EG, Butkus D, Olsen TG et al (1988) Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 19(1 Pt 2):176\u2013185","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2152_CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.132.1.94","volume":"132","author":"RB Sollitto","year":"1996","unstructured":"Sollitto RB, DiGiovanna JJ (1996) Failure of interferon alfa and isotretinoin combination therapy in the nevoid basal cell carcinoma syndrome. Arch Dermatol 132(1):94\u201395","journal-title":"Arch Dermatol"},{"issue":"5","key":"2152_CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/oxfordjournals.annonc.a058881","volume":"5","author":"S Toma","year":"1994","unstructured":"Toma S, Palumbo R, Vincenti M, Aitini E, Paganini G, Pronzato P et al (1994) Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma. Ann Oncol 5(5):463\u2013465","journal-title":"Ann Oncol"},{"issue":"4","key":"2152_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-107-4-499","volume":"107","author":"SM Lippman","year":"1987","unstructured":"Lippman SM, Meyskens FL Jr (1987) Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107(4):499\u2013502","journal-title":"Ann Intern Med"},{"issue":"4","key":"2152_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jnci\/84.4.235","volume":"84","author":"SM Lippman","year":"1992","unstructured":"Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM et al (1992) 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84(4):235\u2013241","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2152_CR23","first-page":"1315","volume":"66","author":"FL Meyskens Jr","year":"1982","unstructured":"Meyskens FL Jr, Gilmartin E, Alberts DS, Levine NS, Brooks R, Salmon SE et al (1982) Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 66(6):1315\u20131319","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"2152_CR24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dth.12062","volume":"27","author":"N Skroza","year":"2014","unstructured":"Skroza N, Proietti I, Tolino E, Bernardini N, La Viola G, Nicolucci F et al (2014) Isotretinoin for the treatment of squamous cell carcinoma arising on an epidermoid cyst. Dermatol Ther 27(2):94\u201396","journal-title":"Dermatol Ther"},{"issue":"1","key":"2152_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007890-199601150-00040","volume":"61","author":"BA Bellman","year":"1996","unstructured":"Bellman BA, Eaglstein WH, Miller J (1996) Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. Transplantation 61(1):173","journal-title":"Transplantation"},{"issue":"1","key":"2152_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-4632.2006.02948.x","volume":"46","author":"RJ Feldman","year":"2007","unstructured":"Feldman RJ, Maize JC (2007) Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas. Int J Dermatol 46(1):77\u201379","journal-title":"Int J Dermatol"},{"issue":"10","key":"2152_CR27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198009043031005","volume":"303","author":"RP Haydey","year":"1980","unstructured":"Haydey RP, Reed ML, Dzubow LM, Shupack JL (1980) Treatment of keratoacanthomas with oral 13-cis-retinoic acid. N Engl J Med 303(10):560\u2013562","journal-title":"N Engl J Med"},{"issue":"9","key":"2152_CR28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archderm.1984.01650450097029","volume":"120","author":"N Levine","year":"1984","unstructured":"Levine N, Miller RC, Meyskens FL Jr (1984) Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas. Arch Dermatol 120(9):1215\u20131217","journal-title":"Arch Dermatol"},{"issue":"5 Pt 2","key":"2152_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0190-9622(86)70268-5","volume":"15","author":"JC Shaw","year":"1986","unstructured":"Shaw JC, White CR Jr (1986) Treatment of multiple keratoacanthomas with oral isotretinoin. J Am Acad Dermatol 15(5 Pt 2):1079\u20131082","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2152_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2340\/00015555764042","volume":"76","author":"M Schaller","year":"1996","unstructured":"Schaller M, Korting HC, Wolff H, Schirren CG, Burgdorf W (1996) Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: development in a single patient and treatment with oral isotretinoin. Acta Derm Venereol 76(1):40\u201342","journal-title":"Acta Derm Venereol"},{"issue":"24","key":"2152_CR31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198612113152401","volume":"315","author":"WK Hong","year":"1986","unstructured":"Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315(24):1501\u20131505","journal-title":"N Engl J Med"},{"issue":"25","key":"2152_CR32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","volume":"318","author":"KH Kraemer","year":"1988","unstructured":"Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL (1988) Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318(25):1633\u20131637","journal-title":"N Engl J Med"},{"issue":"4","key":"2152_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1179\/joc.1999.11.4.313","volume":"11","author":"M Saade","year":"1999","unstructured":"Saade M, Debahy NE, Houjeily S (1999) Clinical remission of xeroderma pigmentosum-associated squamous cell carcinoma with isotretinoin and chemotherapy: case report. J Chemother 11(4):313\u2013317","journal-title":"J Chemother"},{"issue":"2","key":"2152_CR34","first-page":"255","volume":"26","author":"S Zaman","year":"2014","unstructured":"Zaman S, Gillani JA, Nabeela N, Khattak R, Iqbal I, Ul-Ain N et al (2014) Role of isotretinoin in cancer prevention and management in malignancies associated with xeroderma pigmentosum. J Ayub Med Coll Abbottabad 26(2):255\u2013257","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"1\u20132","key":"2152_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-3835(97)04663-6","volume":"114","author":"TE Moon","year":"1997","unstructured":"Moon TE, Levine N, Cartmel B, Bangert JL (1997) Retinoids in prevention of skin cancer. Cancer Lett 114(1\u20132):203\u2013205","journal-title":"Cancer Lett"},{"issue":"11","key":"2152_CR36","first-page":"957","volume":"6","author":"N Levine","year":"1997","unstructured":"Levine N, Moon TE, Cartmel B, Bangert JL, Rodney S, Dong Q et al (1997) Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomark Prev. 6(11):957\u2013961","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"11","key":"2152_CR37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1346-8138.1992.tb03766.x","volume":"19","author":"KH Kraemer","year":"1992","unstructured":"Kraemer KH, DiGiovanna JJ, Peck GL (1992) Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 19(11):715\u2013718","journal-title":"J Dermatol"},{"issue":"1","key":"2152_CR38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ijd.12191","volume":"53","author":"E Bagatin","year":"2014","unstructured":"Bagatin E, Guadanhim LR, Enokihara MM, Sanudo A, Talarico S, Miot HA et al (2014) Low-dose oral isotretinoin versus topical retinoic acid for photoaging: a randomized, comparative study. Int J Dermatol 53(1):114\u2013122","journal-title":"Int J Dermatol"},{"issue":"2","key":"2152_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-4632.2009.04310.x","volume":"49","author":"E Bagatin","year":"2010","unstructured":"Bagatin E, Parada MO, Miot HA, Hassun KM, Michalany N, Talarico S (2010) A randomized and controlled trial about the use of oral isotretinoin for photoaging. Int J Dermatol 49(2):207\u2013214","journal-title":"Int J Dermatol"},{"issue":"7","key":"2152_CR40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1524-4725.2000.99210.x","volume":"26","author":"E Hernandez-Perez","year":"2000","unstructured":"Hernandez-Perez E, Khawaja HA, Alvarez TY (2000) Oral isotretinoin as part of the treatment of cutaneous aging. Dermatol Surg 26(7):649\u2013652","journal-title":"Dermatol Surg"},{"issue":"2","key":"2152_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1468-3083.2008.02947.x","volume":"23","author":"RM Rabello-Fonseca","year":"2009","unstructured":"Rabello-Fonseca RM, Azulay DR, Luiz RR, Mandarim-de-Lacerda CA, Cuzzi T, Manela-Azulay M (2009) Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. J Eur Acad Dermatol Venereol 23(2):115\u2013123","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2152_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/ijd.14363","volume":"58","author":"M Ianhez","year":"2019","unstructured":"Ianhez M, Pinto SA, Miot HA, Bagatin E (2019) A randomized, open, controlled trial of tretinoin 0.05% cream vs low-dose oral isotretinoin for the treatment of field cancerization. Int J Dermatol. 58(3):365\u2013373","journal-title":"Int J Dermatol."},{"issue":"4","key":"2152_CR43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1590\/abd1806-4841.20153703","volume":"90","author":"BS Bravo","year":"2015","unstructured":"Bravo BS, Azulay DR, Luiz RR, Mandarim-De-Lacerda CA, Cuzzi T, Azulay MM (2015) Oral isotretinoin in photoaging: objective histological evidence of efficacy and durability. An Bras Dermatol 90(4):479\u2013486","journal-title":"An Bras Dermatol"},{"issue":"2 Pt 1","key":"2152_CR44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)70287-1","volume":"36","author":"CA Sander","year":"1997","unstructured":"Sander CA, Pfeiffer C, Kligman AM, Plewig G (1997) Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 36(2 Pt 1):236\u2013238","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2152_CR45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1540-9740.2007.07145.x","volume":"7","author":"CL Kalil","year":"2008","unstructured":"Kalil CL, Fachinello FZ, Lamb FM, Comunello LN (2008) Use of oral isotretinoin in photoaging therapy. Skinmed 7(1):10\u201314","journal-title":"Skinmed"},{"issue":"5","key":"2152_CR46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/84.5.328","volume":"84","author":"JA Tangrea","year":"1992","unstructured":"Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ et al (1992) Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst. 84(5):328\u2013332","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"2152_CR47","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0190-9622(96)90282-0","volume":"34","author":"M Duvic","year":"1996","unstructured":"Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF et al (1996) Combined modality therapy for cutaneous T cell lymphoma. J Am Acad Dermatol 34(6):1022\u20131029","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2152_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mjd.2003.449","volume":"49","author":"M Duvic","year":"2003","unstructured":"Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R (2003) Analysis of long-term outcomes of combined modality therapy for cutaneous T cell lymphoma. J Am Acad Dermatol 49(1):35\u201349","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"2152_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0190-9622(91)70036-2","volume":"24","author":"RM Knobler","year":"1991","unstructured":"Knobler RM, Trautinger F, Radaszkiewicz T, Kokoschka EM, Micksche M (1991) Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 24(2 Pt 1):247\u2013252","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2152_CR50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/09546634.2018.1487525","volume":"30","author":"I Amitay-Laish","year":"2019","unstructured":"Amitay-Laish I, Reiter O, Prag-Naveh H, Kershenovich R, Hodak E (2019) Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work? J Dermatolog Treat 30(3):258\u2013263","journal-title":"J Dermatolog Treat"},{"issue":"8964","key":"2152_CR51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(95)91137-5","volume":"345","author":"K Thomsen","year":"1995","unstructured":"Thomsen K (1995) Cutaneous T cell lymphoma and calcitriol and isotretinoin treatment. Lancet 345(8964):1583","journal-title":"Lancet"},{"issue":"4","key":"2152_CR52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2141.1993.tb03235.x","volume":"85","author":"IJ Su","year":"1993","unstructured":"Su IJ, Cheng AL, Tsai TF, Lay JD (1993) Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes. Br J Haematol 85(4):826\u2013828","journal-title":"Br J Haematol"},{"issue":"4","key":"2152_CR53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0190-9622(85)80446-1","volume":"13","author":"GL Wantzin","year":"1985","unstructured":"Wantzin GL, Thomsen K (1985) A new cutaneous side effect of isotretinoin. J Am Acad Dermatol 13(4):665","journal-title":"J Am Acad Dermatol"},{"issue":"8350","key":"2152_CR54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(83)90717-1","volume":"2","author":"RP Warrell Jr","year":"1983","unstructured":"Warrell RP Jr, Coonley CJ, Kempin SJ, Myskowski P, Safai B, Itri LM (1983) Isotretinoin in cutaneous T cell lymphoma. Lancet 2(8350):629","journal-title":"Lancet"},{"issue":"3","key":"2152_CR55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1987.00370030133026","volume":"147","author":"SM Neely","year":"1987","unstructured":"Neely SM, Mehlmauer M, Feinstein DI (1987) The effect of isotretinoin in six patients with cutaneous T cell lymphoma. Arch Intern Med 147(3):529\u2013531","journal-title":"Arch Intern Med"},{"issue":"3","key":"2152_CR56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2340\/0001555567232236","volume":"67","author":"L Molin","year":"1987","unstructured":"Molin L, Thomsen K, Volden G, Aronsson A, Hammar H, Hellbe L et al (1987) Oral retinoids in mycosis fungoides and Sezary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol. 67(3):232\u2013236","journal-title":"Acta Derm Venereol."},{"issue":"6","key":"2152_CR57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/0001555564563566","volume":"64","author":"K Thomsen","year":"1984","unstructured":"Thomsen K, Molin L, Volden G, Lange Wantzin G, Hellbe L (1984) 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol. 64(6):563\u2013566","journal-title":"Acta Derm Venereol."},{"issue":"2","key":"2152_CR58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1987.01660260071016","volume":"123","author":"JF Kessler","year":"1987","unstructured":"Kessler JF, Jones SE, Levine N, Lynch PJ, Booth AR, Meyskens FL Jr (1987) Isotretinoin and cutaneous helper T cell lymphoma (mycosis fungoides). Arch Dermatol 123(2):201\u2013204","journal-title":"Arch Dermatol"},{"issue":"6","key":"2152_CR59","first-page":"536","volume":"69","author":"K Thomsen","year":"1989","unstructured":"Thomsen K, Hammar H, Molin L, Volden G (1989) Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol. 69(6):536\u2013538","journal-title":"Acta Derm Venereol."},{"issue":"6","key":"2152_CR60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1524-4725.1986.tb01961.x","volume":"12","author":"JE Fitzpatrick","year":"1986","unstructured":"Fitzpatrick JE, Mellette JR (1986) Treatment of mycosis fungoides with isotretinoin. J Dermatol Surg Oncol 12(6):626\u2013629","journal-title":"J Dermatol Surg Oncol"},{"issue":"1","key":"2152_CR61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.2005.06360.x","volume":"152","author":"M Leverkus","year":"2005","unstructured":"Leverkus M, Rose C, Brocker EB, Goebeler M (2005) Follicular cutaneous T cell lymphoma: beneficial effect of isotretinoin for persisting cysts and comedones. Br J Dermatol 152(1):193\u2013194","journal-title":"Br J Dermatol"},{"issue":"8338","key":"2152_CR62","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(83)92136-0","volume":"1","author":"JF Kessler","year":"1983","unstructured":"Kessler JF, Meyskens FL Jr, Levine N, Lynch PJ, Jones SE (1983) Treatment of cutaneous T cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1(8338):1345\u20131347","journal-title":"Lancet"},{"issue":"5","key":"2152_CR63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1529-8019.2006.00083.x","volume":"19","author":"C Zhang","year":"2006","unstructured":"Zhang C, Duvic M (2006) Treatment of cutaneous T cell lymphoma with retinoids. Dermatol Ther 19(5):264\u2013271","journal-title":"Dermatol Ther"},{"issue":"3","key":"2152_CR64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","volume":"130","author":"GA Ertl","year":"1994","unstructured":"Ertl GA, Levine N, Kligman AM (1994) A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 130(3):319\u2013324","journal-title":"Arch Dermatol"},{"issue":"7","key":"2152_CR65","first-page":"505","volume":"8","author":"H Gollnick","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szabo EL, Meyer KG, Hauptmann P, Popp G et al (2010) Systemic isotretinoin in the treatment of rosacea\u2014doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8(7):505\u2013515","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"2152_CR66","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jid.2016.01.025","volume":"136","author":"E Sbidian","year":"2016","unstructured":"Sbidian E, Vicaut E, Chidiack H, Anselin E, Cribier B, Dreno B et al (2016) A Randomized-controlled trial of oral low-dose isotretinoin for difficult-to-treat papulopustular rosacea. J Invest Dermatol 136(6):1124\u20131129","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2152_CR67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/00015555-0888","volume":"90","author":"O Bostanci","year":"2010","unstructured":"Bostanci O, Borelli C, Schaller M (2010) Treatment of extrafacial rosacea with low-dose isotretinoin. Acta Derm Venereol 90(4):409\u2013410","journal-title":"Acta Derm Venereol"},{"key":"2152_CR68","doi-asserted-by":"crossref","unstructured":"Debroy Kidambi A, Tiffin NJ, Ramsay HM (2016) Atypical rosacea in a male patient: case study. Dermatol Online J 22(2)","DOI":"10.5070\/D3222030101"},{"issue":"5","key":"2152_CR69","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2230.1984.tb00842.x","volume":"9","author":"JR Marsden","year":"1984","unstructured":"Marsden JR, Shuster S, Neugebauer M (1984) Response of rosacea to isotretinoin. Clin Exp Dermatol 9(5):484\u2013488","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2152_CR70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2340\/00015555641521","volume":"64","author":"JB Schmidt","year":"1984","unstructured":"Schmidt JB, Gebhart W, Raff M, Spona J (1984) 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol. 64(1):15\u201321","journal-title":"Acta Derm Venereol."},{"issue":"1","key":"2152_CR71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555678991","volume":"67","author":"K Turjanmaa","year":"1987","unstructured":"Turjanmaa K, Reunala T (1987) Isotretinoin treatment of rosacea. Acta Derm Venereol 67(1):89\u201391","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"2152_CR72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-1204","volume":"92","author":"M Uslu","year":"2012","unstructured":"Uslu M, Savk E, Karaman G, Sendur N (2012) Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements. Acta Derm Venereol 92(1):73\u201377","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"2152_CR73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ajd.12505","volume":"58","author":"JS Wee","year":"2017","unstructured":"Wee JS, Tan KB (2017) Phymatous rosacea presenting with leonine facies and clinical response to isotretinoin. Australas J Dermatol 58(1):72\u201373","journal-title":"Australas J Dermatol"},{"issue":"7","key":"2152_CR74","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","volume":"134","author":"FG Erdogan","year":"1998","unstructured":"Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F (1998) Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134(7):884\u2013885","journal-title":"Arch Dermatol"},{"issue":"10","key":"2152_CR75","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-4362.1986.tb04533.x","volume":"25","author":"E Hoting","year":"1986","unstructured":"Hoting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25(10):660\u2013663","journal-title":"Int J Dermatol"},{"issue":"1","key":"2152_CR76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ajd.12522","volume":"59","author":"M Rademaker","year":"2018","unstructured":"Rademaker M (2018) Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients. Australas J Dermatol 59(1):26\u201330","journal-title":"Australas J Dermatol"},{"key":"2152_CR77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jocd.12982","volume":"19","author":"HH Kwon","year":"2019","unstructured":"Kwon HH, Jung JY, Lee WY, Bae Y, Park GH (2019) Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low-dose isotretinoin. J Cosmet Dermatol 19:105\u2013111","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"2152_CR78","first-page":"40","volume":"4","author":"WL McFalda","year":"2011","unstructured":"McFalda WL, Roebuck HL (2011) Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report. J Clin Aesthet Dermatol 4(1):40\u201342","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"2152_CR79","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1111\/pde.13143","volume":"34","author":"K Marquis","year":"2017","unstructured":"Marquis K, Christensen LC, Rajpara A (2017) Dissecting cellulitis of the scalp with excellent response to isotretinoin. Pediatr Dermatol 34(4):e210\u2013e211","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"2152_CR80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjd.13999","volume":"174","author":"A Badaoui","year":"2016","unstructured":"Badaoui A, Reygagne P, Cavelier-Balloy B, Pinquier L, Deschamps L, Crickx B et al (2016) Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature. Br J Dermatol 174(2):421\u2013423","journal-title":"Br J Dermatol"},{"issue":"10","key":"2152_CR81","first-page":"1219","volume":"16","author":"CN Lee","year":"2018","unstructured":"Lee CN, Chen W, Hsu CK, Weng TT, Lee JY, Yang CC (2018) Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66-patient case series and proposal of classification. J Dtsch Dermatol Ges 16(10):1219\u20131226","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"2152_CR82","first-page":"8","volume":"18","author":"JP Mundi","year":"2012","unstructured":"Mundi JP, Marmon S, Fischer M, Kamino H, Patel R, Shapiro J (2012) Dissecting cellulitis of the scalp. Dermatol Online J 18(12):8","journal-title":"Dermatol Online J"},{"issue":"2","key":"2152_CR83","first-page":"98","volume":"19","author":"LL Mihic","year":"2011","unstructured":"Mihic LL, Tomas D, Situm M, Krolo I, Sebetic K, Sjerobabski-Masnec I et al (2011) Perifolliculitis capitis abscedens et suffodiens in a caucasian: diagnostic and therapeutic challenge. Acta Dermatovenerol Croat 19(2):98\u2013102","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"2152_CR84","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.1996.tb07952.x","volume":"134","author":"L Scerri","year":"1996","unstructured":"Scerri L, Williams HC, Allen BR (1996) Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 134(6):1105\u20131108","journal-title":"Br J Dermatol"},{"issue":"3","key":"2152_CR85","first-page":"195","volume":"82","author":"S Georgala","year":"2008","unstructured":"Georgala S, Korfitis C, Ioannidou D, Alestas T, Kylafis G, Georgala C (2008) Dissecting cellulitis of the scalp treated with rifampicin and isotretinoin: case reports. Cutis 82(3):195\u2013198","journal-title":"Cutis"},{"key":"2152_CR86","first-page":"2123037","volume":"2016","author":"JM Hintze","year":"2016","unstructured":"Hintze JM, Howard BE, Donald CB, Hayden RE (2016) Surgical management and reconstruction of Hoffman\u2019s disease (dissecting cellulitis of the scalp). Case Rep Surg 2016:2123037","journal-title":"Case Rep Surg"},{"issue":"10","key":"2152_CR87","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1468-3083.2007.02239.x","volume":"21","author":"A Khaled","year":"2007","unstructured":"Khaled A, Zeglaoui F, Zoghlami A, Fazaa B, Kamoun MR (2007) Dissecting cellulitis of the scalp: response to isotretinoin. J Eur Acad Dermatol Venereol 21(10):1430\u20131431","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"2152_CR88","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-4362.2002.01552_3.x","volume":"41","author":"R Koca","year":"2002","unstructured":"Koca R, Altinyazar HC, Ozen OI, Tekin NS (2002) Dissecting cellulitis in a white male: response to isotretinoin. Int J Dermatol 41(8):509\u2013513","journal-title":"Int J Dermatol"},{"issue":"4","key":"2152_CR89","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1111\/jdv.13948","volume":"31","author":"G Segurado-Miravalles","year":"2017","unstructured":"Segurado-Miravalles G, Camacho-Martinez FM, Arias-Santiago S, Serrano-Falcon C, Serrano-Ortega S, Rodrigues-Barata R et al (2017) Epidemiology, clinical presentation and therapeutic approach in a multicentre series of dissecting cellulitis of the scalp. J Eur Acad Dermatol Venereol 31(4):e199\u2013e200","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2152_CR90","first-page":"36","volume":"5","author":"U Wollina","year":"2012","unstructured":"Wollina U, Gemmeke A, Koch A (2012) Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist. J Clin Aesthet Dermatol 5(4):36\u201339","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"2152_CR91","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1524-4725.1992.tb02920.x","volume":"18","author":"T Bachynsky","year":"1992","unstructured":"Bachynsky T, Antonyshyn OM, Ross JB (1992) Dissecting folliculitis of the scalp. A case report of combined treatment using tissue expansion, radical excision, and isotretinoin. J Dermatol Surg Oncol. 18(10):877\u2013880","journal-title":"J Dermatol Surg Oncol."},{"issue":"1","key":"2152_CR92","first-page":"37","volume":"67","author":"PC Stites","year":"2001","unstructured":"Stites PC, Boyd AS (2001) Dissecting cellulitis in a white male: a case report and review of the literature. Cutis 67(1):37\u201340","journal-title":"Cutis"},{"issue":"5","key":"2152_CR93","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1067\/mjd.2001.113717","volume":"45","author":"CN Ellis","year":"2001","unstructured":"Ellis CN, Krach KJ (2001) Uses and complications of isotretinoin therapy. J Am Acad Dermatol 45(5):S150\u2013S157","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2152_CR94","first-page":"147","volume":"36","author":"SM Schleicher","year":"1985","unstructured":"Schleicher SM, Milstein HJ (1985) Resolution of disseminated granuloma annulare following isotretinoin therapy. Cutis 36(2):147\u2013148","journal-title":"Cutis"},{"issue":"5","key":"2152_CR95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-4362.1992.tb03970.x","volume":"31","author":"SM Schleicher","year":"1992","unstructured":"Schleicher SM, Milstein HJ, Lim SJ, Stanton CD (1992) Resolution of disseminated granuloma annulare with isotretinoin. Int J Dermatol 31(5):371\u2013372","journal-title":"Int J Dermatol"},{"issue":"1","key":"2152_CR96","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0190-9622(95)90210-4","volume":"32","author":"RC Ratnavel","year":"1995","unstructured":"Ratnavel RC, Norris PG (1995) Perforating granuloma annulare: response to treatment with isotretinoin. J Am Acad Dermatol 32(1):126\u2013127","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2152_CR97","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-4362.1996.tb03034.x","volume":"35","author":"WY Tang","year":"1996","unstructured":"Tang WY, Chong LY, Lo KK (1996) Resolution of generalized granuloma annulare with isotretinoin therapy. Int J Dermatol 35(6):455\u2013456","journal-title":"Int J Dermatol"},{"issue":"4","key":"2152_CR98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2230.2000.00640.x","volume":"25","author":"HS Young","year":"2000","unstructured":"Young HS, Coulson IH (2000) Granuloma annulare following waxing induced pseudofolliculitis-resolution with isotretinoin. Clin Exp Dermatol 25(4):274\u2013276","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2152_CR99","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/000155501750208209","volume":"81","author":"E Erkek","year":"2001","unstructured":"Erkek E, Karaduman A, Bukulmez G, Senturk N, Ozkaya O (2001) An unusual form of generalized granuloma annulare in a patient with insulin-dependent diabetes mellitus. Acta Derm Venereol. 81(1):48\u201350","journal-title":"Acta Derm Venereol."},{"issue":"11","key":"2152_CR100","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archderm.138.11.1518","volume":"138","author":"DC Adams","year":"2002","unstructured":"Adams DC, Hogan DJ (2002) Improvement of chronic generalized granuloma annulare with isotretinoin. Arch Dermatol 138(11):1518\u20131519","journal-title":"Arch Dermatol"},{"issue":"4","key":"2152_CR101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D36KQ1P6T8","volume":"9","author":"MP Arroyo","year":"2003","unstructured":"Arroyo MP (2003) Generalized granuloma annulare. Dermatol Online J 9(4):13","journal-title":"Dermatol Online J"},{"issue":"4","key":"2152_CR102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-4362.2003.01799_4.x","volume":"42","author":"A Buendia-Eisman","year":"2003","unstructured":"Buendia-Eisman A, Ruiz-Villaverde R, Blasco-Melguizo J, Serrano-Ortega S (2003) Generalized annular granuloma: response to isotretinoin. Int J Dermatol 42(4):321\u2013322","journal-title":"Int J Dermatol"},{"issue":"2","key":"2152_CR103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4632.2005.02229.x","volume":"44","author":"E Pasmatzi","year":"2005","unstructured":"Pasmatzi E, Georgiou S, Monastirli A, Tsambaos D (2005) Temporary remission of disseminated granuloma annulare under oral isotretinoin therapy. Int J Dermatol 44(2):169\u2013171","journal-title":"Int J Dermatol"},{"issue":"1","key":"2152_CR104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1468-3083.2006.01337.x","volume":"20","author":"MT Sahin","year":"2006","unstructured":"Sahin MT, Turel-Ermertcan A, Ozturkcan S, Turkdogan P (2006) Generalized granuloma annulare in a patient with type II diabetes mellitus: successful treatment with isotretinoin. J Eur Acad Dermatol Venereol 20(1):111\u2013114","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"2152_CR105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1468-3083.2006.01989.x","volume":"21","author":"EB Baskan","year":"2007","unstructured":"Baskan EB, Turan A, Tunali S (2007) A case of generalized granuloma annulare with myelodysplastic syndrome: successful treatment with systemic isotretinoin and topical pimecrolimus 1% cream combination. J Eur Acad Dermatol Venereol 21(5):693\u2013695","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6 Pt 1","key":"2152_CR106","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0190-9622(97)80281-2","volume":"36","author":"BD Clayton","year":"1997","unstructured":"Clayton BD, Jorizzo JL, Hitchcock MG, Fleischer AB, Williford PM, Feldman SR et al (1997) Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol 36(6 Pt 1):959\u2013964","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"2152_CR107","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0190-9622(90)70110-4","volume":"22","author":"M Borok","year":"1990","unstructured":"Borok M, Lowe NJ (1990) Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. J Am Acad Dermatol 22(5 Pt 1):792\u2013795","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2152_CR108","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0190-9622(94)70271-3","volume":"31","author":"CH Dicken","year":"1994","unstructured":"Dicken CH (1994) Treatment of classic pityriasis rubra pilaris. J Am Acad Dermatol 31(6):997\u2013999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2152_CR109","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-4632.2012.05811.x","volume":"53","author":"N Marrouche","year":"2014","unstructured":"Marrouche N, Kurban M, Kibbi AG, Abbas O (2014) Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. Int J Dermatol 53(4):434\u2013439","journal-title":"Int J Dermatol"},{"issue":"3","key":"2152_CR110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1067\/mjd.2002.124619","volume":"47","author":"DS Allison","year":"2002","unstructured":"Allison DS, El-Azhary RA, Calobrisi SD, Dicken CH (2002) Pityriasis rubra pilaris in children. J Am Acad Dermatol 47(3):386\u2013389","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"2152_CR111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0190-9622(87)70038-3","volume":"16","author":"CH Dicken","year":"1987","unstructured":"Dicken CH (1987) Isotretinoin treatment of pityriasis rubra pilaris. J Am Acad Dermatol 16(2 Pt 1):297\u2013301","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2152_CR112","first-page":"380","volume":"25","author":"RS Gilgor","year":"1980","unstructured":"Gilgor RS, Chiaramonti A, Goldsmith LA, Lazarus GS (1980) Evaluation of 13-cis retinoic acid in lamellar ichthyosis, pityriasis rubra pilaris and Darier\u2019s disease. Cutis 25(4):380\u2013381","journal-title":"Cutis"},{"issue":"4 Pt 2 Suppl","key":"2152_CR113","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0190-9622(82)70061-1","volume":"6","author":"LA Goldsmith","year":"1982","unstructured":"Goldsmith LA, Weinrich AE, Shupack J (1982) Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol. 6(4 Pt 2 Suppl):710\u2013715","journal-title":"J Am Acad Dermatol."},{"issue":"Suppl 1","key":"2152_CR114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000250878","volume":"157","author":"GL Peck","year":"1978","unstructured":"Peck GL, Yoder FW, Olsen TG, Pandya MD, Butkus D (1978) Treatment of Darier\u2019s disease, lamellar ichthyosis, pityriasis rubra pilaris, cystic acne, and basal cell carcinoma with oral 13-cis-retinoic acid. Dermatologica 157(Suppl 1):11\u201312","journal-title":"Dermatologica"},{"issue":"5","key":"2152_CR115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2230.1984.tb00841.x","volume":"9","author":"J Risch","year":"1984","unstructured":"Risch J, Ashton RE, Lowe NJ, Chalet M (1984) 13-cis-retinoic acid for dyskeratinizing diseases\u2013clinicopathological responses. Clin Exp Dermatol 9(5):472\u2013483","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"2152_CR116","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1365-4632.2006.02932.x","volume":"45","author":"VN Sehgal","year":"2006","unstructured":"Sehgal VN, Srivastava G, Aggarwal AK, Sardana K, Jain M (2006) Efficacy of isotretinoin in pityriasis rubra pilaris: unapproved use. Int J Dermatol 45(10):1238\u20131240","journal-title":"Int J Dermatol"},{"issue":"3","key":"2152_CR117","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00128071-200506030-00004","volume":"6","author":"M Akyol","year":"2005","unstructured":"Akyol M, Ozcelik S (2005) Non-acne dermatologic indications for systemic isotretinoin. Am J Clin Dermatol 6(3):175\u2013184","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"2152_CR118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0090-4295(99)80094-6","volume":"45","author":"E Cardamakis","year":"1995","unstructured":"Cardamakis E, Kotoulas IG, Relakis K, Metalinos K, Michopoulos J, Stathopoulos E et al (1995) Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Urology 45(5):857\u2013860","journal-title":"Urology"},{"issue":"1","key":"2152_CR119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01370930","volume":"258","author":"EK Cardamakis","year":"1996","unstructured":"Cardamakis EK, Kotoulas IG, Dimopoulos DP, Stathopoulos EN, Michopoulos JT, Tzingounis VA (1996) Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata. Arch Gynecol Obstet 258(1):35\u201341","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2152_CR120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/sti.2003.006841","volume":"80","author":"S Georgala","year":"2004","unstructured":"Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (2004) Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial. Sex Transm Infect 80(3):216\u2013218","journal-title":"Sex Transm Infect"},{"issue":"6","key":"2152_CR121","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(89)70127-4","volume":"20","author":"EA Olsen","year":"1989","unstructured":"Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK (1989) Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 20(6):1023\u20131030","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2152_CR122","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0022-5347(01)64136-3","volume":"158","author":"D Tsambaos","year":"1997","unstructured":"Tsambaos D, Georgiou S, Monastirli A, Sakkis T, Sagriotis A, Goerz G (1997) Treatment of condylomata acuminata with oral isotretinoin. J Urol 158(5):1810\u20131812","journal-title":"J Urol"},{"issue":"2","key":"2152_CR123","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jaad.2017.08.057","volume":"78","author":"AK Jha","year":"2018","unstructured":"Jha AK, Sonthalia S, Ganguly S (2018) Oral isotretinoin as an adjunctive treatment for recurrent genital warts. J Am Acad Dermatol 78(2):e35\u2013e36","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2152_CR124","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/00015555-1257","volume":"92","author":"E Pasmatzi","year":"2012","unstructured":"Pasmatzi E, Kapranos N, Monastirli A, Melachrinou M, Georgiou S, Tsambaos D (2012) Large benign condyloma acuminatum: successful treatment with isotretinoin and interferon alpha. Acta Derm Venereol 92(3):249\u2013250","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"2152_CR125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/dth.12059","volume":"27","author":"YW Yew","year":"2014","unstructured":"Yew YW, Pan JY (2014) Complete remission of recalcitrant genital warts with a combination approach of surgical debulking and oral isotretinoin in a patient with systemic lupus erythematosus. Dermatol Ther. 27(2):79\u201382","journal-title":"Dermatol Ther."},{"issue":"9","key":"2152_CR126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1742-1241.2004.00071.x","volume":"58","author":"M Yildirim","year":"2004","unstructured":"Yildirim M, Inaloz HS, Baysal V, Kesici D, Candir O (2004) A case of condyloma acuminatum treated successfully with low-dose isotretinoin and interferon. Int J Clin Pract 58(9):889\u2013891","journal-title":"Int J Clin Pract"},{"key":"2152_CR127","first-page":"1","volume":"26","author":"N Patel","year":"2019","unstructured":"Patel N, McKenzie SA, Harview CL, Truong AK, Shi VY, Chen L et al (2019) Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study. J Dermatolog Treat 26:1\u20133","journal-title":"J Dermatolog Treat"},{"issue":"2\u20133","key":"2152_CR128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000477207","volume":"233","author":"CM Huang","year":"2017","unstructured":"Huang CM, Kirchhof MG (2017) A new perspective on isotretinoin treatment of hidradenitis suppurativa: a retrospective chart review of patient outcomes. Dermatology 233(2\u20133):120\u2013125","journal-title":"Dermatology"},{"issue":"2","key":"2152_CR129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","volume":"218","author":"A Soria","year":"2009","unstructured":"Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F et al (2009) Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment. Dermatology 218(2):134\u2013135","journal-title":"Dermatology"},{"issue":"3","key":"2152_CR130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(84)70199-X","volume":"11","author":"CH Dicken","year":"1984","unstructured":"Dicken CH, Powell ST, Spear KL (1984) Evaluation of isotretinoin treatment of hidradenitis suppurativa. J Am Acad Dermatol 11(3):500\u2013502","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2152_CR131","first-page":"252","volume":"107","author":"DH Jones","year":"1982","unstructured":"Jones DH, Cunliffe WJ, King K (1982) Hidradenitis suppurativa-lack of success with 13-cis-retinoic acid. Br J Dermatol 107(2):252","journal-title":"Br J Dermatol"},{"issue":"6","key":"2152_CR132","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2230.1986.tb00512.x","volume":"11","author":"JF Norris","year":"1986","unstructured":"Norris JF, Cunliffe WJ (1986) Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin. Clin Exp Dermatol 11(6):579\u2013583","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"2152_CR133","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1111\/pde.12891","volume":"33","author":"J Ornelas","year":"2016","unstructured":"Ornelas J, Sivamani R, Awasthi S (2016) A report of two patients with darier disease and hidradenitis suppurativa. Pediatr Dermatol 33(4):e265\u2013e266","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"2152_CR134","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/ced.13953","volume":"44","author":"AR Jorgensen","year":"2019","unstructured":"Jorgensen AR, Thomsen SF, Ring HC (2019) Isotretinoin and hidradenitis suppurativa. Clin Exp Dermatol 44(4):e155\u2013e156","journal-title":"Clin Exp Dermatol"},{"issue":"1 Pt 2","key":"2152_CR135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0190-9622(85)80013-X","volume":"12","author":"CS Burton","year":"1985","unstructured":"Burton CS, Sawchuk WS (1985) Premature sebaceous gland hyperplasia: successful treatment with isotretinoin. J Am Acad Dermatol 12(1 Pt 2):182\u2013184","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2152_CR136","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0190-9622(97)70082-3","volume":"37","author":"R Grimalt","year":"1997","unstructured":"Grimalt R, Ferrando J, Mascaro JM (1997) Premature familial sebaceous hyperplasia: successful response to oral isotretinoin in three patients. J Am Acad Dermatol 37(6):996\u2013998","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2152_CR137","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ced.12918","volume":"41","author":"V Gupta","year":"2016","unstructured":"Gupta V, Mridha AR, Sharma VK (2016) Sebaceous hyperplasia and sebaceous adenomas presenting as leonine facies and improving with oral isotretinoin. Clin Exp Dermatol 41(8):923\u2013924","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"2152_CR138","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5021\/ad.2016.28.2.271","volume":"28","author":"HY Jung","year":"2016","unstructured":"Jung HY, Kim M, Cho BK, Park HJ (2016) A case of cyclosporine-induced sebaceous hyperplasia in a renal transplant patient successfully treated with isotretinoin. Ann Dermatol 28(2):271\u2013272","journal-title":"Ann Dermatol"},{"issue":"10","key":"2152_CR139","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/1346-8138.13416","volume":"43","author":"YS Liu","year":"2016","unstructured":"Liu YS, Cheng YP, Liu CI, Yang CY, Yang CY (2016) Presenile diffuse familial sebaceous hyperplasia successfully treated with low-dose isotretinoin: a report of two cases and review of the published work. J Dermatol 43(10):1205\u20131208","journal-title":"J Dermatol"},{"issue":"3","key":"2152_CR140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-0960.2011.00776.x","volume":"52","author":"SK McDonald","year":"2011","unstructured":"McDonald SK, Goh MS, Chong AH (2011) Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients. Australas J Dermatol 52(3):227\u2013230","journal-title":"Australas J Dermatol"},{"issue":"2","key":"2152_CR141","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/j.1365-4632.2012.05823.x","volume":"53","author":"S Noh","year":"2014","unstructured":"Noh S, Shin JU, Jung JY, Lee JH (2014) A case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatment. Int J Dermatol 53(2):e151\u2013e153","journal-title":"Int J Dermatol"},{"issue":"2","key":"2152_CR142","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/abd1806-4841.20153192","volume":"90","author":"S Tagliolatto","year":"2015","unstructured":"Tagliolatto S, Santos Neto-Ode O, Alchorne MM, Enokihara MY (2015) Sebaceous hyperplasia: systemic treatment with isotretinoin. An Bras Dermatol. 90(2):211\u2013215","journal-title":"An Bras Dermatol."},{"issue":"1","key":"2152_CR143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0378-6323.162346","volume":"82","author":"W Wang","year":"2016","unstructured":"Wang W, Qiu Y, Zhou G, Pei Z, Zhang F (2016) Premature sebaceous hyperplasia with satisfactory response to oral isotretinoin. Indian J Dermatol Venereol Leprol. 82(1):113","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"3","key":"2152_CR144","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-4632.2004.02408.x","volume":"44","author":"VN Sehgal","year":"2005","unstructured":"Sehgal VN, Srivastava G (2005) Darier\u2019s (Darier-White) disease\/keratosis follicularis. Int J Dermatol 44(3):184\u2013192","journal-title":"Int J Dermatol"},{"issue":"3","key":"2152_CR145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1346-8138.13230","volume":"43","author":"A Takagi","year":"2016","unstructured":"Takagi A, Kamijo M, Ikeda S (2016) Darier disease. J Dermatol 43(3):275\u2013279","journal-title":"J Dermatol"},{"issue":"10","key":"2152_CR146","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1515\/jom-1986-861013","volume":"86","author":"JQ Del Rosso","year":"1986","unstructured":"Del Rosso JQ, Horowitz DC (1986) Treatment of Darier\u2019s disease with isotretinoin: report of a case. J Am Osteopath Assoc 86(10):634\u2013638","journal-title":"J Am Osteopath Assoc"},{"issue":"1","key":"2152_CR147","first-page":"7","volume":"13","author":"C Kim","year":"2007","unstructured":"Kim C, Fangman W (2007) Keratosis follicularis (Darier-White disease), with an unusual palmoplantar keratoderma. Dermatol Online J 13(1):7","journal-title":"Dermatol Online J"},{"issue":"6","key":"2152_CR148","doi-asserted-by":"crossref","first-page":"18574","DOI":"10.5070\/D3196018574","volume":"19","author":"C Udayashankar","year":"2013","unstructured":"Udayashankar C, Nath AK, Anuradha P (2013) Extensive Darier\u2019s disease with pityriasis amiantacea, alopecia and congenital facial nerve palsy. Dermatol Online J 19(6):18574","journal-title":"Dermatol Online J"},{"issue":"1","key":"2152_CR149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaad.2004.08.011","volume":"52","author":"AM Rotunda","year":"2005","unstructured":"Rotunda AM, Cotliar J, Haley JC, Craft N (2005) Unilateral Darier\u2019s disease associated with migraine headache responsive to isotretinoin. J Am Acad Dermatol 52(1):175\u2013176","journal-title":"J Am Acad Dermatol"},{"issue":"4 Pt 2 Suppl","key":"2152_CR150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0190-9622(82)80052-2","volume":"6","author":"CH Dicken","year":"1982","unstructured":"Dicken CH, Bauer EA, Hazen PG, Krueger GG, Marks JG Jr, McGuire JS et al (1982) Isotretinoin treatment of Darier\u2019s disease. J Am Acad Dermatol. 6(4 Pt 2 Suppl):721\u2013726","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"2152_CR151","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/phpp.12125","volume":"30","author":"P Gahalaut","year":"2014","unstructured":"Gahalaut P, Soodan PS, Mishra N, Rastogi MK, Soodan HS, Chauhan S (2014) Clinical efficacy of psoralen + sunlight vs combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study. Photodermatol Photoimmunol Photomed. 30(6):294\u2013301","journal-title":"Photodermatol Photoimmunol Photomed."},{"issue":"3","key":"2152_CR152","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0781.2011.00581.x","volume":"27","author":"H Mortazavi","year":"2011","unstructured":"Mortazavi H, Khezri S, Hosseini H, Khezri F, Vasigh M (2011) A single blind randomized clinical study: the efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed 27(3):159\u2013161","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"2152_CR153","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1525-1470.2007.00524.x","volume":"24","author":"H Al-Shobaili","year":"2007","unstructured":"Al-Shobaili H, Al-Khenaizan S (2007) Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol. 24(5):563\u2013564","journal-title":"Pediatr Dermatol."},{"issue":"5","key":"2152_CR154","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2133.1997.tb03680.x","volume":"136","author":"A Anstey","year":"1997","unstructured":"Anstey A, Hawk JL (1997) Isotretinoin-PUVA in women with psoriasis. Br J Dermatol 136(5):798\u2013799","journal-title":"Br J Dermatol"},{"issue":"8318","key":"2152_CR155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0140-6736(83)92607-7","volume":"1","author":"H Honigsmann","year":"1983","unstructured":"Honigsmann H, Wolff K (1983) Isotretinoin-PUVA for psoriasis. Lancet 1(8318):236","journal-title":"Lancet"},{"issue":"8367","key":"2152_CR156","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(84)90196-X","volume":"1","author":"HL Sofen","year":"1984","unstructured":"Sofen HL, Moy RL, Lowe NJ (1984) Treatment of generalised pustular psoriasis with isotretinoin. Lancet 1(8367):40","journal-title":"Lancet"},{"key":"2152_CR157","doi-asserted-by":"crossref","unstructured":"Wilken R, Sharma A, Patel F, Maverakis E (2015) Successful treatment of palmoplantar pustulosis with isotretinoin. Dermatol Online J 21(8)","DOI":"10.5070\/D3218028439"},{"issue":"10","key":"2152_CR158","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archderm.1985.01660100077019","volume":"121","author":"RL Moy","year":"1985","unstructured":"Moy RL, Kingston TP, Lowe NJ (1985) Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. Arch Dermatol 121(10):1297\u20131301","journal-title":"Arch Dermatol"},{"issue":"3","key":"2152_CR159","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","volume":"27","author":"L Okon","year":"2013","unstructured":"Okon L, Werth V (2013) Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol 27(3):391\u2013404","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"2152_CR160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-4362.1990.tb03476.x","volume":"29","author":"BB Furner","year":"1990","unstructured":"Furner BB (1990) Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 29(8):587\u2013590","journal-title":"Int J Dermatol"},{"issue":"7","key":"2152_CR161","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","volume":"4","author":"P Fabbri","year":"2003","unstructured":"Fabbri P, Cardinali C, Giomi B, Caproni M (2003) Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 4(7):449\u2013465","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2152_CR162","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1986.01660140060018","volume":"122","author":"RC Newton","year":"1986","unstructured":"Newton RC, Jorizzo JL, Solomon AR Jr, Sanchez RL, Daniels JC, Bell JD et al (1986) Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. Arch Dermatol 122(2):170\u2013176","journal-title":"Arch Dermatol"},{"issue":"5 Pt 2","key":"2152_CR163","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0190-9622(86)70111-4","volume":"14","author":"DJ Rubenstein","year":"1986","unstructured":"Rubenstein DJ, Huntley AC (1986) Keratotic lupus erythematosus: treatment with isotretinoin. J Am Acad Dermatol 14(5 Pt 2):910\u2013914","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 2","key":"2152_CR164","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0190-9622(87)70214-X","volume":"17","author":"SG Green","year":"1987","unstructured":"Green SG, Piette WW (1987) Successful treatment of hypertrophic lupus erythematosus with isotretinoin. J Am Acad Dermatol 17(2 Pt 2):364\u2013368","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2152_CR165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0190-9622(91)70008-P","volume":"24","author":"JK Shornick","year":"1991","unstructured":"Shornick JK, Formica N, Parke AL (1991) Isotretinoin for refractory lupus erythematosus. J Am Acad Dermatol 24(1):49\u201352","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2152_CR166","first-page":"183","volume":"66","author":"TT Richardson","year":"2000","unstructured":"Richardson TT, Cohen PR (2000) Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. Cutis 66(3):183\u2013188","journal-title":"Cutis"},{"issue":"3","key":"2152_CR167","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1529-8019.2012.01461.x","volume":"25","author":"AM D'Erme","year":"2012","unstructured":"D\u2019Erme AM, Milanesi N, Difonzo EM, Lotti T, Gola M (2012) Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option. Dermatol Ther 25(3):281\u2013282","journal-title":"Dermatol Ther"},{"issue":"1","key":"2152_CR168","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/09546634.2013.869302","volume":"26","author":"MG Olguin-Garcia","year":"2015","unstructured":"Olguin-Garcia MG, Jurado-Santa Cruz F, Peralta-Pedrero ML, Morales-Sanchez MA (2015) A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatolog Treat 26(1):78\u201382","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"2152_CR169","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/ijd.13727","volume":"56","author":"GJ Kaur","year":"2017","unstructured":"Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B (2017) Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol 56(12):1352\u20131358","journal-title":"Int J Dermatol"},{"key":"2152_CR170","first-page":"163929","volume":"2012","author":"HR Al-Hamamy","year":"2012","unstructured":"Al-Hamamy HR, Salman HA, Abdulsattar NA (2012) Treatment of plane warts with a low-dose oral isotretinoin. ISRN Dermatol 2012:163929","journal-title":"ISRN Dermatol"},{"issue":"3","key":"2152_CR171","first-page":"63","volume":"21","author":"J Miljkovic","year":"2012","unstructured":"Miljkovic J (2012) A novel therapeutic approach to plane warts: a report on two cases. Acta Dermatovenerol Alp Pannonica Adriat 21(3):63\u201364","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"2","key":"2152_CR172","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5114\/pdia.2017.70259","volume":"35","author":"A Bialecka","year":"2018","unstructured":"Bialecka A, Mecinska-Jundzill K, Adamska U, Cichewicz A, Bialecki M, Drewa G et al (2018) Plane warts on the back of the hand successfully treated with oral isotretinoin. Postepy Dermatol Alergol 35(2):227\u2013229","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"2152_CR173","doi-asserted-by":"crossref","first-page":"e12836","DOI":"10.1111\/dth.12836","volume":"32","author":"DD Dave","year":"2019","unstructured":"Dave DD, Abdelmaksoud A (2019) Low dose isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: a case series. Dermatol Ther 32(2):e12836","journal-title":"Dermatol Ther"},{"issue":"9","key":"2152_CR174","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jdv.13052","volume":"29","author":"JK Tietze","year":"2015","unstructured":"Tietze JK, Heppt MV, von Preussen A, Wolf U, Ruzicka T, Wolff H et al (2015) Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients. J Eur Acad Dermatol Venereol 29(9):1816\u20131821","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2152_CR175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijd.13874","volume":"57","author":"B Aksoy","year":"2018","unstructured":"Aksoy B, Hapa A, Mutlu E (2018) Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study. Int J Dermatol 57(2):250\u2013253","journal-title":"Int J Dermatol"},{"issue":"1","key":"2152_CR176","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2310\/7750.2014.13218","volume":"19","author":"MJ Bunagan","year":"2015","unstructured":"Bunagan MJ, Banka N, Shapiro J (2015) Retrospective review of folliculitis decalvans in 23 patients with course and treatment analysis of long-standing cases. J Cutan Med Surg. 19(1):45\u201349","journal-title":"J Cutan Med Surg."},{"issue":"5","key":"2152_CR177","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaad.2018.05.1240","volume":"79","author":"L Miguel-Gomez","year":"2018","unstructured":"Miguel-Gomez L, Rodrigues-Barata AR, Molina-Ruiz A, Martorell-Calatayud A, Fernandez-Crehuet P, Grimalt R et al (2018) Folliculitis decalvans: effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up. J Am Acad Dermatol 79(5):878\u2013883","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2152_CR178","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/ijt.ijt_34_18","volume":"10","author":"F Shireen","year":"2018","unstructured":"Shireen F, Sudhakar A (2018) A case of isotretinoin therapy-refractory folliculitis decalvans treated successfully with biosimilar adalimumab (exemptia). Int J Trichol 10(5):240\u2013241","journal-title":"Int J Trichol"},{"issue":"4","key":"2152_CR179","first-page":"184","volume":"15","author":"A Gemmeke","year":"2006","unstructured":"Gemmeke A, Wollina U (2006) Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin, and prednisolone. Acta Dermatovenerol Alp Pannonica Adriat 15(4):184\u2013186","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"6","key":"2152_CR180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/09546634.2018.1542480","volume":"30","author":"H Babahosseini","year":"2019","unstructured":"Babahosseini H, Tavakolpour S, Mahmoudi H, Balighi K, Teimourpour A, Ghodsi SZ et al (2019) Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients. J Dermatolog Treat 30(6):598\u2013604","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"2152_CR181","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/ced.13203","volume":"42","author":"F Mardones","year":"2017","unstructured":"Mardones F, Shapiro J (2017) Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience. Clin Exp Dermatol 42(7):755\u2013759","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"2152_CR182","first-page":"988","volume":"16","author":"A Rakowska","year":"2017","unstructured":"Rakowska A, Gradzinska A, Olszewska M, Rudnicka L (2017) Efficacy of isotretinoin and acitretin in treatment of frontal fibrosing alopecia: retrospective analysis of 54 cases. J Drugs Dermatol 16(10):988\u2013992","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"2152_CR183","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jdcr.2020.01.030","volume":"6","author":"CT Pham","year":"2020","unstructured":"Pham CT, Hosking AM, Cox S, Mesinkovska NA (2020) Therapeutic response of facial papules and inflammation in frontal fibrosing alopecia to low-dose oral isotretinoin. JAAD Case Rep 6(5):453\u2013456","journal-title":"JAAD Case Rep"},{"issue":"4","key":"2152_CR184","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jaad.2017.04.1118","volume":"77","author":"AF Pedrosa","year":"2017","unstructured":"Pedrosa AF, Duarte AF, Haneke E, Correia O (2017) Yellow facial papules associated with frontal fibrosing alopecia: a distinct histologic pattern and response to isotretinoin. J Am Acad Dermatol 77(4):764\u2013766","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2152_CR185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000464334","volume":"3","author":"R Pirmez","year":"2017","unstructured":"Pirmez R, Duque-Estrada B, Barreto T, Quintella DC, Cuzzi T (2017) Successful treatment of facial papules in frontal fibrosing alopecia with oral isotretinoin. Skin Appendage Disord 3(2):111\u2013113","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"2152_CR186","doi-asserted-by":"crossref","first-page":"e12633","DOI":"10.1111\/dth.12633","volume":"31","author":"N Namazi","year":"2018","unstructured":"Namazi N, Niknezhad N, Niknejad N, Asadi-Kani Z (2018) Familial facial lichen planopilaris and satisfactory response to isotretinoin. Dermatol Ther 31(5):e12633","journal-title":"Dermatol Ther"},{"issue":"9","key":"2152_CR187","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ijd.13293","volume":"55","author":"SK Muthu","year":"2016","unstructured":"Muthu SK, Narang T, Saikia UN, Kanwar AJ, Parsad D, Dogra S (2016) Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol 55(9):1048\u20131054","journal-title":"Int J Dermatol"},{"issue":"4","key":"2152_CR188","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0190-9622(84)80285-6","volume":"10","author":"HL Handler","year":"1984","unstructured":"Handler HL (1984) Isotretinoin for oral lichen planus. J Am Acad Dermatol 10(4):674","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2152_CR189","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0030-4220(86)90288-4","volume":"62","author":"C Camisa","year":"1986","unstructured":"Camisa C, Allen CM (1986) Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 62(4):393\u2013396","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"4","key":"2152_CR190","first-page":"301","volume":"68","author":"AS Boyd","year":"2001","unstructured":"Boyd AS, King LE (2001) Lichenoid drug reaction from isotretinoin therapy. Cutis 68(4):301\u2013303","journal-title":"Cutis"},{"issue":"4","key":"2152_CR191","first-page":"385","volume":"35","author":"TY Woo","year":"1985","unstructured":"Woo TY (1985) Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35(4):385\u2013386 (90\u20131, 93)","journal-title":"Cutis"},{"issue":"1","key":"2152_CR192","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clindermatol.2009.03.005","volume":"28","author":"D Rigopoulos","year":"2010","unstructured":"Rigopoulos D, Larios G, Katsambas AD (2010) The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies. Clin Dermatol. 28(1):24\u201330","journal-title":"Clin Dermatol."},{"key":"2152_CR193","unstructured":"Administration UFaD (2005) iPLEDGE program. Available from: http:\/\/www.ipledgeprogram.com\/"},{"issue":"14","key":"2152_CR194","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.279.14.1057-JMN0408-2-1","volume":"279","author":"L Lamberg","year":"1998","unstructured":"Lamberg L (1998) Acne drug depression warnings highlight need for expert care. JAMA 279(14):1057","journal-title":"JAMA"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02152-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T11:11:07Z","timestamp":1697022667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":194,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02152-4","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"13 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors do not have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}